Anúncio
Anúncio

LFCR

LFCR logo

Lifecore Biomedical, Inc. Common Stock

7.57
USD
Patrocinado
-0.20
-2.64%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

7.57

0.00
0.00%

Relatórios de Lucros LFCR

Rácio de surpresa positiva

LFCR separação 20 de 35 últimas estimativas.

57%

Próximo Relatório

Data do Próximo Relatório
01 de abr. de 2026
Estimate for Q3 26 (Revenue/ EPS)
$32.20M
/
-$0.22
Mudanças implicadas de Q2 26 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-8.41%
/
-53.19%

Lifecore Biomedical, Inc. Common Stock earnings per share and revenue

On 02 de jan. de 2026, LFCR reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.19 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 32.99 milhão, with a --% difference.
Looking ahead to Q3 26, 7 analistas forecast an EPS of -0.22 USD, with revenue projected to reach 32.20 milhão USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q2 2026, Lifecore Biomedical, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 01 de abr. de 2026.
Based on 7 analistas, Lifecore Biomedical, Inc. Common Stock is expected to report EPS of -$0.22 and revenue of $32.20M for Q3 2026.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio